Ecocardiografia con stress farmacologico: Dobutamina o dipiridamolo?

Giornale Italiano di Cardiologia

Volumn 26, Issue 4, 1996, Pages 447-453

  Salustri, Alessandro ^c   Trocino, Giuseppe ^a   Fioretti, Paolo ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SANDRO PERTINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE;

ANGINA PECTORIS; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HUMAN; REVIEW;

ADRENERGIC BETA-AGONISTS; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY; EVALUATION STUDIES; HUMANS; MYOCARDIAL ISCHEMIA; PARASYMPATHOLYTICS; PROGNOSIS; SYMPATHOMIMETICS; VASODILATOR AGENTS;

EID: 0030458576     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Picano E: Stress echocardiography. 2nd Edition. Berlin/Heidelberg/New York/Tokyo, Springer-Verlag, 1994.
2. Ruffolo RR: Review: The pharmacology of dobutamine. Am J Med Sci 1987; 294: 244-248.
3. Picano E: Dipyridamole-echocardiography test: the historical background and the physiologic basis. Eur Heart J 1989; 10: 365-376.
4. Picano E, Marini C, Pirelli S et al, on behalf of the Echo-Persantine International Cooperative Study Group: Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 1992; 70: 252-258.
5. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M, on behalf of the Echo Dobutamine International Cooperative Study Group: Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190-1192.
6. Poldermans D, Fioretti PM, Boersma E et al: Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease: experience in 650 consecutive examinations. Am J Cardiol 1994; 73: 456-459.
7. Mertes H, Sawada SG, Ryan T et al: Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 1993; 88: 15-19.
8. Chiarella F, Domenicucci S, Bellotti P, Bellone P, Scarsi G, Vecchio C: Dipyridamole echocardiographic test performed 3 days after on acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. Eur Heart J 1994; 15: 842-850.
9. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR: Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Inter Med 1992; 116: 190-196.
10. Picano E, Masini M, Lattanzi F et al: Short-term reproducibility of dipyridamole-echocardiography test. Clin Cardiol 1987; 10: 588-590.
11. Bellotti P, Fioretti PM, Forster T, McNeill AJ, El-Said EM, Roelandt JRTC: Reproducibility of dobutamine-atropine stress test. Echocardiography 1993; 10: 93-97.
12. El-Said EM, Rijsterborgh H, Roelandt JRTC, Wetter WB, Fioretti P, Linker D: Reproducibility of transmitral pulsed Doppler parameters of left ventricular filling during dobutamine stress test. Echocardiography 1994; 11: 445-452.
13. Lattanzi F, Picano E, Bolognese L et al: Inhibition of dipyridamole-induced ischemia by antianginal medication therapy in humans. Correlation with exercise electrocardiography. Circulation 1991; 83: 1256-1262.
14. Fioretti PM, Poldermans D, Salustri A et al: Atropine increases the accuracy of dobutamine stress echocardiography in patients taking betablockers. Eur Heart J 1994; 15: 355-360.
15. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roelandt JRTC: Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41-46.
16. Picano E, Pingitore A, Conti U et al: Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J, 1993; 14: 1216-1222.
17. Previtali M, Lanzarini L, Ferrario M, Tortorici M, Mussini A, Montemartini C: Dobutamine venus dipyridamole echocardiography in coronary artery disease. Circulation 1992; 83 (Suppl III): III-27-III-31.
18. Salustri A, Fioretti PM, McNeill AJ, Pozzoli MMA, Roelandt JRTC: Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischemia: a comparison between dobutamine and dipyridamole. Eur Heart J 1992; 13: 1356-1362.
19. Previtali M, Lanzarini L, Fetiveau R et al: Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol 1993; 72: 865-870.
20. Beleslin BD, Ostojic M, Stepanovic J et al: Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994; 90: 1168-1176.
21. Pingitore A, Gigli G, Quartacolosso M et al on behalf of the EPIC-EDIC study group: The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1994; 1A-484A.
22. Dagianti A, Penco M, Agati L et al: Stress echocardiography: Comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995; 26: 18-25.
23. Cigarroa CG, deFilippi CR, Brickner E, Alvarez LG, Wait MA, Grayburn PA: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430-436.
24. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
25. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991; 122: 1522-1531.
26. Marzullo P, Parodi O, Reisenhofer B et al: Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for defecting myocardial viability. Am J Cardiol 1993; 71: 166-172.
27. Smart SC, Sawada S, Ryan T et al: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
28. Salustri A, Elhendy A, Garyfallidis P et al: Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994; 74: 853-856.
29. Picano E, Marzullo P, Gigli G et al: Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol 1992; 70: 703-710.
30. Picano E, Severi S, Michelassi C et al: Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 1989; 80: 450-457.
31. Severi S, Picano E, Michelassi C et al: Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease: comparison with exercise electrocardiography. Circulation 1994; 89: 1160-1173.
32. Picano E, Landi P, Bolognese L, for the EPIC Study Group: Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: A large-scale, multicenter trial. Am J Med 1995; 95: 608-618.
33. Mazeika PK, Nadazdin A, Oakly CM: Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. Am J Cardiol 1993; 71: 33-39.
34. Afridi I, Quinones MA, Zoghbi WA, Cheirif J: Dobutamine stress echocardiography: Sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994; 127: 1510-1515.
35. Poldermans D, Fioretti PM, Boersma E et al: Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med 1994; 97: 119-125.
36. Pingitore A, Vorga A, Bigi R et al on behalf of the EDIC and the EPIC Study Group: The prognostic impact of dobutamine versus dipyridamole stress echocardiography. Circulation 1995; 92: I-411.
37. Lane RT, Sawada SG, Segar DS et al: Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 1991; 68: 976-977.
38. Lalka SG, Sawada SG, Dalsing MC et al: Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992; 15: 831-842.
39. Eichelberger JP, Schwatz KQ, Black ER, Green RM, Ouriel K: Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993; 72: 602-607.
40. Davila-Roman VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Perez JE: Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993; 21: 957-977.
41. Poldermans D, Fioretti PM, Forster T et al: Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993; 87: 1506-1512.
42. Tischler MD, Lee TH, Hirsch AT: Prediction of major events following peripheral vascular surgery using dipyridamole echocardiography. Am J Cardiol 1991; 68: 593-597.
43. Sicari R, Picano E, Lusa AM et al on behalf of the EPIC: The value of dipyridamole echocardiography in risk stratification before vascular surgery. A multicenter study. Eur Heart J 1995; 16: 842-847.
44. Mairesse GH, Marwick TH, Arnese M et al: Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography. Am J Cardiol 1995 (in press).
45. Senior R, Lahiri A: Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26: 26-32.